[ASAP] Patent Review of Novel Biologics Targeting Opioid Use Disorder (2018–2024) 🔗 Access full article via ACS Chemical NeuroscienceShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
